ONCS OncoSec Medical Incorporated

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * China Grand Pharmaceutical & Healthcare Holdings Ltd	2. Issuer Name and Ticker or Trading Symbol ONCOSEC MEDICAL Inc [ ONCS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    __X__ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) C/O CHAO ZHOU, UNIT 3302, 33/F,, THE CENTER, 99 QUEEN'S ROAD CENTRAL	3. Date of Earliest Transaction (MM/DD/YYYY) 4/16/2021
(Street) HONG KONG,   (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	4/16/2021		P		1409838	A	$3.45	16798036	I	See Footnote (1)
Common Stock	4/16/2021		P		281968	A	$3.45	3359607	I	See Footnote (2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:
(1)	Securities held by Grand Decade Developments Limited, a wholly owned subsidiary of the Reporting Person.
(2)	Securities held by Sirtex Medical US Holdings, Inc., an affiliate of the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Remarks: The Reporting Persons may be deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Each Reporting Person disclaims beneficial ownership of any securities deemed to be owned by the group that are not directly owned by the Reporting Person. This report shall not be deemed an admission that such Reporting Person is a member of a group or the beneficial owner of any securities not directly owned by such Reporting Person.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
China Grand Pharmaceutical & Healthcare Holdings Ltd C/O CHAO ZHOU, UNIT 3302, 33/F, THE CENTER, 99 QUEEN'S ROAD CENTRAL HONG KONG		X
Grand Decade Developments Ltd C/O CHAO ZHOU, UNIT 3302, 33/F, THE CENTER, 99 QUEEN'S ROAD CENTRAL HONG KONG		X		See Remarks
Sirtex Medical US Holdings, Inc. 300 UNICORN PARK DRIVE WOBURN, MA 01801		X		See Remarks

Signatures
/s/ Caterina Benson by Power of Attorney for China Grand Pharmaceutical and Healthcare Holdings Limited		4/26/2021
**Signature of Reporting Person		Date
/s/ Caterina Benson by Power of Attorney for Grand Decade Developments Limited		4/26/2021
**Signature of Reporting Person		Date
/s/ Caterina Benson by Power of Attorney for Sirtex Medical US Holdings, Inc.		4/26/2021
**Signature of Reporting Person		Date